HIS-ALA-ASP-ALA-VAL-PHE-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2
HIS-ALA-ASP-ALA-VAL-PHE-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2 Basic information
- Product Name:
- HIS-ALA-ASP-ALA-VAL-PHE-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2
- Synonyms:
-
- [ALA2,8,9,11,19,22,24,25,27,28]-VIP
- HIS-ALA-ASP-ALA-VAL-PHE-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2
- L-Alaninamide, L-histidyl-L-alanyl-L-α-aspartyl-L-alanyl-L-valyl-L-phenylalanyl-L-threonyl-L-alanyl-L-alanyl-L-tyrosyl-L-alanyl-L-arginyl-L-leucyl-L-arginyl-L-lysyl-L-glutaminyl-L-methionyl-L-alanyl-L-alanyl-L-lysyl-L-lysyl-L-alanyl-L-leucyl-L-alanyl-L-alanyl-L-isoleucyl-L-alanyl-
- His-A-D-A-Val-F-THR-A-Ala-Tyr-A-Arg-L-Arg-K-Gln-Me
- CAS:
- 866552-34-3
- MF:
- C131H219N41O33S
- MW:
- 2928.46
- Mol File:
- 866552-34-3.mol
More
Less
HIS-ALA-ASP-ALA-VAL-PHE-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2 Chemical Properties
- Density
- 1.42±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- Soluble to 2 mg/ml in 10% acetonitrile
- form
- Powder
- Sequence
- His-Ala-Asp-Ala-Val-Phe-Thr-Ala-Ala-Tyr-Ala-Arg-Leu-Arg-Lys-Gln-Met-Ala-Ala-Lys-Lys-Ala-Leu-Ala-Ala-Ile-Ala-Ala-NH2
More
Less
HIS-ALA-ASP-ALA-VAL-PHE-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2 Usage And Synthesis
Description
Highly selective agonist for the VPAC1 receptor (IC50 values are ~ 15-13.2 and > 30000 nM for VPAC1 and VPAC2 receptors respectively).
Uses
[Ala2,8,9,11,19,22,24,25,27,28]-VIP is an analog vasoactive intestinal polypeptide (VIP) with high affinity and selectivity for human VIP/pituitary adenylate cyclase-activating polypeptide 1 (hVPAC1). VIP is a widespread neurotransmitter[1].
References
[1] Hisato Igarashi, et al. Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors. J Pharmacol Exp Ther. 2005 Oct;315(1):370-81. DOI:10.1124/jpet.105.088823
HIS-ALA-ASP-ALA-VAL-PHE-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2Supplier
3B Pharmachem (Wuhan) International Co.,Ltd.
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
Nanchang Tianzhen Biotechnology Co., Ltd
- Tel
- 13758194781 13173652190
- 522013271@qq.com
Biosynth Biological Technology (Suzhou) Co Ltd
- Tel
- 51288865780
- sales@biosynth.com
Hangzhou ALLPEPTIDE Biotechnology Co., Ltd.
- Tel
- 17342063383
- sales@allpeptide.com
ApexBio Technology
- Tel
- + 1-832-696-8203
- sales@apexbt.com